Thus, our results suggest that the overexpression of either gene is sufficient to not only restore the decreased IP3R activity caused by deficits in WFS1 or CISD2 but also ameliorate the diabetic complications that WS patients experience. This evidence concerns the gene WFS1 and Werner syndrome.